BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 9360526)

  • 1. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors.
    Hunt JL; Yim JH; Tometsko M; Finkelstein SD; Swalsky P; Carty SE
    Surgery; 2003 Dec; 134(6):1043-7; discussion 1047-8. PubMed ID: 14668739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
    Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F
    Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
    Ward LS; Brenta G; Medvedovic M; Fagin JA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
    Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
    Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
    Rodrigues-Serpa A; Catarino A; Soares J
    Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.
    Moore PS; Zamboni G; Brighenti A; Lissandrini D; Antonello D; Capelli P; Rigaud G; Falconi M; Scarpa A
    Am J Pathol; 2001 Jan; 158(1):317-21. PubMed ID: 11141506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
    Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
    Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas.
    Fogt F; Vortmeyer AO; Stolte M; Mueller E; Mueller J; Noffsinger A; Poremba C; Zhuang Z
    Hum Pathol; 1998 Sep; 29(9):961-4. PubMed ID: 9744312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
    Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
    Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
    Simsir A; Palacios D; Linehan WM; Merino MJ; Abati A
    Diagn Cytopathol; 2001 May; 24(5):328-32. PubMed ID: 11335962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.